Skip to main content

Table 1 Characteristics of the SSc cohort (n = 44)

From: Nailfold videocapillaroscopy and serum VEGF levels in scleroderma are associated with internal organ involvement

 

SSc (n = 44)

F (%) vs M (%)

42 (95.4 %) vs 2 (4.6 %)

Median age, yy(range)

66 (34–80)

Median disease duration, yy (range)

9 (1–16)

D (%) vs L (%)

10 (22.7 %) vs 34 (77.3 %)

anti-Scl70 (+) (%)

12 (27.3 %)

ACA (+) (%)

22 (50 %)

Others Abs (%)a

10 (22.7 %)

Iloprost (%)

25 (56.8 %)

Bosentan (%)

7 (15.9 %)

Ulcers (%)

15 (34.1 %)

Early NVC pattern (%)

6 (13.6 %)

Active NVC pattern (%)

20 (45.4 %)

Late NVC pattern (%)

18 (40.9 %)

GE disease (%)

36 (81.8 %)

sPAP >45 mmHg (%)

3 (6.8 %)

DLCO <50 % (%)

DLCO/AV <50 % (%)

7 (15.9 %)

1 (2.3 %)

FVC <80 % (%)

8 (18.2 %)

Honeycombing lung (%)

4 (9.1 %)

Rodnan skin score >14 (%)

9 (20.4 %)

  1. ACA anti-centromere, anti-Scl70 anti-topoisomerase, AV alveolar volume, D diffuse, DLCO carbon monoxide diffusing capacity, F female, FVC forced vital capacity, GE gastro-esophageal, L limited, M male, NVC nailfold videocapillaroscopy, sPAP systolic pulmonary artery pressure on echocardiography, SSc systemic sclerosis, vs versus
  2. a1/10 anti-Ku, 2/10 anti-RNApol III, 1/10 anti-Th/To